NCT04095611 (HemiSPAIRE) is a NA clinical trial of SPAIRE in Hip Fracture, sponsored by Royal Devon and Exeter NHS Foundation Trust.

Who is sponsoring NCT04095611?

NCT04095611 is sponsored by Royal Devon and Exeter NHS Foundation Trust.

What drugs are being tested in NCT04095611?

Interventions in NCT04095611: SPAIRE, LATERAL.

What condition does NCT04095611 study?

NCT04095611 studies Hip Fracture.

Is NCT04095611 still recruiting?

NCT04095611 is currently completed. Last updated 11 January 2024.

Last reviewed 2024-01-11 · How we verify

NCT04095611: HemiSPAIRE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Modified Muscle Sparing Posterior Technique (SPAIRE) in Hip Hemiarthroplasty for Displaced Intracapsular Fractures.

Completed NA Last updated 11 January 2024

What this trial tests

NA trial testing SPAIRE in Hip Fracture in 244 participants. Completed in 19 August 2022.

Timeline

25 November 2019

Primary endpoint
19 August 2022

19 August 2022

Quick facts

Lead sponsor	Royal Devon and Exeter NHS Foundation Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	244
Start date	25 November 2019
Primary completion	19 August 2022
Estimated completion	19 August 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

SPAIRE
LATERAL

Conditions studied

Hip Fracture — all drugs for Hip Fracture →

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Who can join

60 and older, any sex, with Hip Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Which technique is best for partial hip replacement?

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical effectiveness of a modified muscle sparing posterior technique compared with a standard lateral approach in hip hemiarthroplasty for displaced intracapsular fractures (HemiSPAIRE): a multicenter, parallel-group, randomized controlled trial.
Ball S, Aylward A, Cockcroft E, Corr A, et al · · 2024 · cited 8× · PMID 38895600 · DOI 10.1136/bmjsit-2023-000251
Effects of a modified muscle sparing posterior technique in hip hemiarthroplasty for displaced intracapsular fractures on postoperative function compared to a standard lateral approach (HemiSPAIRE): protocol for a randomised controlled trial.
Price A, Ball S, Rhodes S, Wickins R, et al · · 2021 · cited 7× · PMID 34103316 · DOI 10.1136/bmjopen-2020-045652
Detailed statistical analysis plan for a randomised controlled trial of the effects of a modified muscle sparing posterior technique (SPAIRE) in hip hemiarthroplasty for displaced intracapsular fractures on post-operative function compared to a standard lateral approach: HemiSPAI
Ball S, McAndrew A, Aylward A, Cockcroft E, et al · · 2022 · cited 1× · PMID 36335403 · DOI 10.1186/s13063-022-06790-z
Detailed statistical analysis plan for a randomised controlled trial of the effects of a modified muscle sparing posterior technique (SPAIRE) in hip hemiarthroplasty for displaced intracapsular fractures on post-operative function compared to a standard lateral approach: HemiSPAI
Ball S, McAndrew A, Aylward A, Cockcroft E, et al · · 2022 · DOI 10.21203/rs.3.rs-1961008/v1

Verify or expand the search:

Other trials of SPAIRE

Trials testing the same drug.

NCT06146205 — The Hip Fracture Surgical Approach Trial · NA · active not recruiting

Other recruiting trials for Hip Fracture

Currently open trials in the same condition.

NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
NCT07113483 — Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery · Phase 3 · recruiting
NCT06898814 — The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery · Phase 4 · recruiting
NCT06818409 — Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergo · recruiting
NCT07202208 — Effectiveness of the Delirium Zero Protocol to Prevent the Onset of Delirium in Patients Undergoing Hip Fracture Surgery · NA · recruiting

Other Royal Devon and Exeter NHS Foundation Trust trials

Trials by the same sponsor.

NCT06685874 — Interstitial Lung Disease Exacerbations Study · active not recruiting
NCT06903780 — Experience of Biologic Treatments for Severe Asthma: a Survey · recruiting
NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting
NCT06523452 — Laser Speckle Imaging During Breast Reconstruction · NA · recruiting
NCT06099691 — Outcomes That Matter and Questionnaires for Older People With Frailty · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04095611 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Royal Devon and Exeter NHS Foundation Trust
Last refreshed: 11 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04095611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing